title: Postmarketing surveillance for drug safety: surely we can do better.
authors.affiliation: Department of Preventive Medicine, Vanderbilt University Medical Center, and Geriatric Research and Education Clinical Center, Veterans Affairs Tennessee Valley Healthcare System, Nashville, 37232, USA. marie.griffin@vanderbilt.edu
authors.forename: Marie R
authors.initials: MR
authors.lastname: Griffin
authors.forename: C Michael
authors.initials: CM
authors.lastname: Stein
authors.forename: Wayne A
authors.initials: WA
authors.lastname: Ray
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use; D004358:Drug Therapy / Q000592:standards / Q000639:trends; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D011358:Product Surveillance, Postmarketing / Q000379:methods* / Q000592:standards* / Q000639:trends
chemical_list: D018501:Antirheumatic Agents